The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 275.3M (2021) → 365.0M (2025)
Holista CollTech Limited is a biotechnology firm with operations spanning Australia, Malaysia, and the United States. Its business activities are organized into four key divisions: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The company specializes in the production and distribution of dietary supplements, cosmetic-quality collagen, and a variety of health-conscious food ingredients. These innovative food products include low-glycemic index (GI) flour blends suitable for noodles, pasta, flatbreads, and other baked goods, along with low-sodium salt, reduced-fat fried options, and both less-calorie and low-GI sugar alternatives. Furthermore, Holista CollTech offers solutions for infection control. Its corporate headquarters are located in Subiaco, Australia.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
+3.6% YoY
YoY Growth Rate
Slow revenue growth
-677.8% YoY
YoY Growth Rate
Earnings declining
A$36,066/ year
↓ Declining (-50% vs prior year)
0.6% of revenue
Below sector average (18%)
R&D spend declining — could signal cost-cutting or efficiency
~1 months
A$564,563 cash & investments
Quarterly Free Cash Flow
→ Burn rate stable
Short runway — potential dilution ahead through share issuance
Holista Colltech Limited has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Earnings per share down more than 10%. Either a bad year, or a real decline.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Free cash flow is negative. They are burning cash, not generating it.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
